Most Read Articles
6 days ago
Regardless of birth weight, being obese at preschool age is associated with a greater risk of elevated blood pressure during early childhood, a recent China study has found. A longer duration of breastfeeding appears to help mitigate such a risk.
Jairia Dela Cruz, 4 days ago
In patients with heart failure with preserved ejection fraction (HFpEF), angiotensin-neprilysin inhibition with sacubitril/valsartan confers better renoprotection than valsartan alone, reducing the risk of adverse renal events and the speed of decline in estimated glomerular filtration rate (eGFR), a study has found.
4 days ago
Dupilumab solution for injection (pre-filled syringe) 200 mg/1.14 mL and 300 mg/2 mL
03 Sep 2020

Empagliflozin significantly reduces cardiovascular (CV) death or hospitalization for heart failure (HHF), as well as renal events, vs placebo in patients with HF with reduced ejection fraction (HFrEF) with or without diabetes mellitus (DM), according to results of the EMPEROR-Reduced trial presented at the European Society of Cardiology (ESC) Congress 2020.

Product Highlight - Vyzulta

4 days ago
Breakthrough in Glaucoma Treatment Over 20 Years.

One Molecule, Two Outflow Pathways.

- Lowers IOP by increasing outflow through both the trabecular meshwork and uveoscleral pathway1
- Greater mean diurnal IOP reduction from baseline vs Latanoprost 0.005%2
- Superior IOP reduction vs Timolol 0.5% at all tested time points3
- Demonstrated safety profile3,4


Please refer to full package insert for the details.

References:
1. Cavet ME, DeCory HH. The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies. J Ocul Pharmacol Ther 2018; 34(1-2): 52-60.
2. Weinreb RN, Ong T, Scassellati Sforzolini B, et al. A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study. Br J Ophthalmol 2015; 99(6): 738-45.
3. Weinreb RN, Liebmann JM, Martin KR, et al. Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings. J Glaucoma 2018; 27(1): 7-15.
4. VYZULTA® Hong Kong prescribing information [version: 06/2018].


Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Hong Kong digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Regardless of birth weight, being obese at preschool age is associated with a greater risk of elevated blood pressure during early childhood, a recent China study has found. A longer duration of breastfeeding appears to help mitigate such a risk.
Jairia Dela Cruz, 4 days ago
In patients with heart failure with preserved ejection fraction (HFpEF), angiotensin-neprilysin inhibition with sacubitril/valsartan confers better renoprotection than valsartan alone, reducing the risk of adverse renal events and the speed of decline in estimated glomerular filtration rate (eGFR), a study has found.
4 days ago
Dupilumab solution for injection (pre-filled syringe) 200 mg/1.14 mL and 300 mg/2 mL
03 Sep 2020

Empagliflozin significantly reduces cardiovascular (CV) death or hospitalization for heart failure (HHF), as well as renal events, vs placebo in patients with HF with reduced ejection fraction (HFrEF) with or without diabetes mellitus (DM), according to results of the EMPEROR-Reduced trial presented at the European Society of Cardiology (ESC) Congress 2020.